Xilio Therapeutics, Inc. 是一家生物技术公司,致力于设计免疫疗法以改善癌症患者的免疫系统。公司总部位于马萨诸塞州沃尔瑟姆。
财务指标
营业收入
2026-06-30
$1869.2万
2026-03-31
$1264.8万
2025-12-31
$1368.6万
2025-09-30
$1906.6万
营业支出
2026-06-30
$2218.3万
2026-03-31
$2641.6万
2025-12-31
$2552.2万
2025-09-30
$2099.5万
净利润
2026-06-30
-$637.3万
2026-03-31
-$952.9万
2025-12-31
$1036万
2025-09-30
-$1628.7万
净利润率
2026-06-30
-34.09%
2026-03-31
-75.34%
2025-12-31
75.69%
2025-09-30
-85.42%
每股收益
2026-06-30
$-0.33
2026-03-31
$-0.58
2025-12-31
$0.80
2025-09-30
$-1.54
息税折旧摊销前利润
2026-06-30
-$604.2万
2026-03-31
-$918.5万
2025-12-31
$1068.3万
2025-09-30
-$1594.7万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$1869.2万
$1264.8万
$1368.6万
$1906.6万
营业支出
$2218.3万
$2641.6万
$2552.2万
$2099.5万
净利润
-$637.3万
-$952.9万
$1036万
-$1628.7万
净利润率
-34.09%
-75.34%
75.69%
-85.42%
每股收益
$-0.33
$-0.58
$0.80
$-1.54
息税折旧摊销前利润
-$604.2万
-$918.5万
$1068.3万
-$1594.7万
有效税率
--
--
--
--
常见问题
XLO stock represents ownership shares in Xcelerate Solutions Inc., a company that provides cybersecurity, intelligence, and mission-support services to U.S. government agencies. The ticker XLO trades on the Nasdaq Capital Market. The company generates revenue primarily through federal contracts, with operations spanning cybersecurity, analytics, and technology integration. Because XLO operates in the government services sector, its performance is closely tied to federal spending priorities and contract awards.
Recent performance data for XLO, including daily price changes and trading volume, can be found in the price chart and performance section of this page. Share prices can fluctuate based on contract wins, earnings reports, and broader market conditions. For the most current XLO price movement and recent trends, please refer to the latest data displayed above.
Evaluating XLO's valuation involves comparing its market price to fundamental metrics such as earnings, revenue, and book value. Common tools include the price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA. Investors may also compare these multiples to peers in the government technology and cybersecurity sector. Because XLO operates in a contract-driven industry, its valuation can be influenced by backlog, margins, and contract renewals. The latest valuation ratios for XLO are available on this page.
XLO shares can be traded during regular U.S. market hours, typically 9:30 a.m. to 4:00 p.m. Eastern Time on weekdays. Many brokers also offer pre-market and after-hours trading sessions, though liquidity and price spreads may be less favorable. XLO is listed on the Nasdaq Capital Market. Investors should check with their brokerage for specific trading hours and any extended-hours availability for XLO.
XLO does not currently pay dividends. The company retains its earnings to fund operations, growth initiatives, or debt obligations. For investors seeking income, XLO may not be suitable. To confirm whether XLO's dividend policy has changed, please check the dividend section on this page or the company's investor relations website for the latest updates.
Key risks for XLO include reliance on U.S. government contracts, which can be affected by budget changes, delays, or policy shifts. The company faces competition from larger government services firms, and its financial performance may be sensitive to contract concentrations. Additionally, XLO's relatively small market capitalization can lead to higher price volatility and lower trading liquidity. Changing economic conditions and interest rates can also impact government spending and the company's cost of capital.